Potential siRNA Molecules for Nucleoprotein and M2/L Overlapping Region of Respiratory Syncytial Virus: In Silico Design.
BACKGROUND
Human respiratory syncytial virus (RSV) is a leading cause of severe lower respiratory tract disease in the pediatric population, elderly and in immunosuppressed individuals. Respiratory syncytial virus is also responsible for bronchiolitis, pneumonia, and chronic obstructive pulmonary infections in all age groups. With this high disease burden and the lack of an effective RSV treatment and vaccine, there is a clear need for discovery and development of novel, effective and safe drugs to prevent and treat RSV disease. The most innovative approach is the use of small interfering RNAs (siRNAs) which represent a revolutionary new concept in human therapeutics. The nucleoprotein gene of RSV which is known as the most conserved gene and the M2/L mRNA, which encompass sixty-eight overlapping nucleotides, were selected as suitable targets for siRNA design.


OBJECTIVE
The present study is aimed to design potential siRNAs for silencing nucleoprotein and an overlapping region of M2-L coding mRNAs by computational analysis.


METHODS
Various computational methods (target alignment, similarity search, secondary structure prediction, and RNA interaction calculation) have been used for siRNA designing against different strains of RSV.


RESULTS
In this study, seven siRNA molecules were rationally designed against the nucleoprotein gene and validated using various computational methods for silencing different strains of RSV. Additionally, three effective siRNA molecules targeting the overlapping region of M2/L mRNA were designed.


CONCLUSIONS
This approach provides insight and a validated strategy for chemical synthesis of an antiviral RNA molecule which meets many sequence features for efficient silencing and treatment at the genomic level.
Virology Department, School of Public Health, Tehran University of Medical Sciences, Tehran, IR Iran.
Somayeh
S
Shatizadeh Malekshahi
Department of Microbiology, School of Biology, College of Science, University of Tehran, Tehran, IR Iran.
Ehsan
E
Arefian
Virology Department, School of Public Health, Tehran University of Medical Sciences, Tehran, IR Iran.
Vahid
V
Salimi
Virology Department, School of Public Health, Tehran University of Medical Sciences, Tehran, IR Iran.
Talat
T
Mokhtari Azad
Virology Department, School of Public Health, Tehran University of Medical Sciences, Tehran, IR Iran.
Jila
J
Yavarian
In Silico; RSV; siRNA